{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:26:17Z","timestamp":1793316377818,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12033-024-01329-w","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T13:08:59Z","timestamp":1734786539000},"page":"4542-4562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Computational Evaluation of Fusarium nygamai Compounds as AcrD Efflux Pump Protein Inhibitors of Salmonella Typhimurium"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2353-9047","authenticated-orcid":false,"given":"Lennin Isaac","family":"Garrido-Palazuelos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-0699","authenticated-orcid":false,"given":"Jos\u00e9 Roberto","family":"Aguirre-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9141-4498","authenticated-orcid":false,"given":"Maria Fernanda","family":"Sandoval-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-7342","authenticated-orcid":false,"given":"Mamuna","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0251-1440","authenticated-orcid":false,"given":"Omar","family":"Guerra-Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5093-9476","authenticated-orcid":false,"given":"Haris","family":"Ahmed-Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"11","key":"1329_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41579-021-00561-4","volume":"19","author":"JE Gal\u00e1n","year":"2021","unstructured":"Gal\u00e1n, J. E. (2021). Salmonella Typhimurium and inflammation: A pathogen-centric affair. Nature Reviews Microbiology, 19(11), 716\u2013725. https:\/\/doi.org\/10.1038\/s41579-021-00561-4","journal-title":"Nature Reviews Microbiology"},{"key":"1329_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01916-16","author":"MMC Buckner","year":"2016","unstructured":"Buckner, M. M. C., Blair, J. M. A., La Ragione, R. M., Newcombe, J., Dwyer, D. J., Ivens, A., & Piddock, L. J. V. (2016). Beyond antimicrobial resistance: evidence for a distinct role of the AcrD efflux pump in salmonella biology. MBio. https:\/\/doi.org\/10.1128\/mbio.01916-16","journal-title":"MBio"},{"issue":"11","key":"1329_CR3","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1021\/acsinfecdis.3c00408","volume":"9","author":"SD Akshay","year":"2023","unstructured":"Akshay, S. D., Deekshit, V. K., Mohan Raj, J., & Maiti, B. (2023). Outer membrane proteins and efflux pumps mediated multi-drug resistance in Salmonella: Rising threat to antimicrobial therapy. ACS Infectious Diseases, 9(11), 2072\u20132092. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00408","journal-title":"ACS Infectious Diseases"},{"issue":"11","key":"1329_CR4","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1128\/aac.44.11.3118-3121.2000","volume":"44","author":"LJV Piddock","year":"2000","unstructured":"Piddock, L. J. V., White, D. G., Gensberg, K., Pumbwe, L., & Griggs, D. J. (2000). Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica Serovar Typhimurium. Antimicrobial Agents and Chemotherapy, 44(11), 3118\u20133121. https:\/\/doi.org\/10.1128\/aac.44.11.3118-3121.2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"1329_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.bbapap.2009.02.002","volume":"1794","author":"K Nishino","year":"2009","unstructured":"Nishino, K., Nikaido, E., & Yamaguchi, A. (2009). Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. Biochimica Et Biophysica Acta (BBA)\u2014Proteins and Proteomics, 1794(5), 834\u2013843. https:\/\/doi.org\/10.1016\/j.bbapap.2009.02.002","journal-title":"Biochimica Et Biophysica Acta (BBA)\u2014Proteins and Proteomics"},{"key":"1329_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/9780470920541.ch3","author":"MD Routh","year":"2011","unstructured":"Routh, M. D., Zalucki, Y., Su, C., Long, F., Zhang, Q., Shafer, W. M., & Yu, E. W. (2011). Efflux pumps of the resistance\u2013nodulation\u2013division family: A perspective of their structure, function, and regulation in gram-negative bacteria. Advances in Enzymology-and Related Areas of Molecular Biology. https:\/\/doi.org\/10.1002\/9780470920541.ch3","journal-title":"Advances in Enzymology-and Related Areas of Molecular Biology"},{"issue":"1","key":"1329_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/antibiotics2010163","volume":"2","author":"D Fernando","year":"2013","unstructured":"Fernando, D., & Kumar, A. (2013). Resistance-nodulation-division multidrug efflux pumps in gram-negative bacteria: Role in virulence. Antibiotics, 2(1), 163\u2013181. https:\/\/doi.org\/10.3390\/antibiotics2010163","journal-title":"Antibiotics"},{"issue":"13","key":"1329_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14715\/cmb\/2018.64.13.15","volume":"64","author":"M Shahini Shams Abadi","year":"2018","unstructured":"Shahini Shams Abadi, M., Gholipour, A., & Hadi, N. (2018). The highly conserved domain of RND multidrug efflux pumps in pathogenic gram-negative bacteria. Cellular and Molecular Biology, 64(13), 79\u201383. https:\/\/doi.org\/10.14715\/cmb\/2018.64.13.15","journal-title":"Cellular and Molecular Biology"},{"issue":"7","key":"1329_CR9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/antibiotics10070774","volume":"10","author":"M Zwama","year":"2021","unstructured":"Zwama, M., & Nishino, K. (2021). Ever-adapting RND efflux pumps in gram-negative multidrug-resistant pathogens: A race against time. Antibiotics, 10(7), 774. https:\/\/doi.org\/10.3390\/antibiotics10070774","journal-title":"Antibiotics"},{"issue":"23","key":"1329_CR10","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1128\/jb.184.23.6490-6499.2002","volume":"184","author":"CA Elkins","year":"2002","unstructured":"Elkins, C. A., & Nikaido, H. (2002). Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominately by two large periplasmic loops. Journal of Bacteriology, 184(23), 6490\u20136498. https:\/\/doi.org\/10.1128\/jb.184.23.6490-6499.2002","journal-title":"Journal of Bacteriology"},{"issue":"6","key":"1329_CR11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1128\/jb.187.6.1923-1929.2005","volume":"187","author":"JR Aires","year":"2005","unstructured":"Aires, J. R., & Nikaido, H. (2005). Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. Journal of Bacteriology, 187(6), 1923\u20131929. https:\/\/doi.org\/10.1128\/jb.187.6.1923-1929.2005","journal-title":"Journal of Bacteriology"},{"issue":"1","key":"1329_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12539-014-0191-3","volume":"6","author":"N Fischer","year":"2014","unstructured":"Fischer, N., Raunest, M., Schmidt, T. H., Koch, D. C., & Kandt, C. (2014). Efflux pump-mediated antibiotics resistance: Insights from computational structural biology. Interdisciplinary Sciences Computational Life Sciences, 6(1), 1\u201312. https:\/\/doi.org\/10.1007\/s12539-014-0191-3","journal-title":"Interdisciplinary Sciences Computational Life Sciences"},{"key":"1329_CR13","doi-asserted-by":"publisher","DOI":"10.2174\/1389557517666170510105506","author":"E Kapp","year":"2017","unstructured":"Kapp, E., Malan, S. F., Joubert, J., & Sampson, S. L. (2017). Small molecule efflux pump inhibitors in Mycobacterium tuberculosis: A rational drug design perspective. Mini-Reviews in Medicinal Chemistry. https:\/\/doi.org\/10.2174\/1389557517666170510105506","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"issue":"1","key":"1329_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/antibiotics12010180","volume":"12","author":"N Compagne","year":"2023","unstructured":"Compagne, N., Vieira Da Cruz, A., M\u00fcller, R. T., Hartkoorn, R. C., Flipo, M., & Pos, K. M. (2023). Update on the discovery of efflux pump inhibitors against critical priority gram-negative bacteria. Antibiotics, 12(1), 180. https:\/\/doi.org\/10.3390\/antibiotics12010180","journal-title":"Antibiotics"},{"issue":"7","key":"1329_CR15","doi-asserted-by":"publisher","first-page":"e101840","DOI":"10.1371\/journal.pone.0101840","volume":"9","author":"V Aparna","year":"2014","unstructured":"Aparna, V., Dineshkumar, K., Mohanalakshmi, N., Velmurugan, D., & Hopper, W. (2014). Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation. PLoS ONE, 9(7), e101840. https:\/\/doi.org\/10.1371\/journal.pone.0101840","journal-title":"PLoS ONE"},{"issue":"4","key":"1329_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jpha.2019.11.002","volume":"10","author":"AJ Seukep","year":"2020","unstructured":"Seukep, A. J., Kuete, V., Nahar, L., Sarker, S. D., & Guo, M. (2020). Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification. Journal of Pharmaceutical Analysis, 10(4), 277\u2013290. https:\/\/doi.org\/10.1016\/j.jpha.2019.11.002","journal-title":"Journal of Pharmaceutical Analysis"},{"issue":"1","key":"1329_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jcc.27215","volume":"45","author":"SS Chauhan","year":"2023","unstructured":"Chauhan, S. S., Gupta, A., Srivastava, A., & Parthasarathi, R. (2023). Discovering targeted inhibitors for Escherichia coli efflux pump fusion proteins using computational and structure-guided approaches. Journal of Computational Chemistry, 45(1), 13\u201324. https:\/\/doi.org\/10.1002\/jcc.27215","journal-title":"Journal of Computational Chemistry"},{"issue":"10","key":"1329_CR18","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.2174\/0929867323666160304150522","volume":"23","author":"HY Mahmood","year":"2016","unstructured":"Mahmood, H. Y., Jamshidi, S., Mark Sutton, J., & Rahman, M. (2016). Current advances in developing inhibitors of bacterial multidrug efflux pumps. Current Medicinal Chemistry, 23(10), 1062\u20131081. https:\/\/doi.org\/10.2174\/0929867323666160304150522","journal-title":"Current Medicinal Chemistry"},{"issue":"7","key":"1329_CR19","doi-asserted-by":"publisher","first-page":"102275","DOI":"10.1016\/j.jksus.2022.102275","volume":"34","author":"R Alenazy","year":"2022","unstructured":"Alenazy, R. (2022). Antibiotic resistance in Salmonella: Targeting multidrug resistance by understanding efflux pumps, regulators and the inhibitors. Journal of King Saud University-Science, 34(7), 102275. https:\/\/doi.org\/10.1016\/j.jksus.2022.102275","journal-title":"Journal of King Saud University-Science"},{"issue":"9","key":"1329_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/1386207319666160720101502","volume":"19","author":"D Choudhury","year":"2016","unstructured":"Choudhury, D., Talukdar, A., Chetia, P., Bhattacharjee, A., & Choudhury, M. (2016). Screening of natural products and derivatives for the identification of RND efflux pump inhibitors. Combinatorial Chemistry & High Throughput Screening, 19(9), 705\u2013713. https:\/\/doi.org\/10.2174\/1386207319666160720101502","journal-title":"Combinatorial Chemistry & High Throughput Screening"},{"issue":"2","key":"1329_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/antibiotics12020421","volume":"12","author":"THT Nguyen","year":"2023","unstructured":"Nguyen, T. H. T., Nguyen, N. T., Nguyen, H. D., Nguyen, T. T. H., Le, M. H., Pham, M. Q., Do, H. N., Hoang, K. C., Michalet, S., Dijoux-Franca, M. G., & Pham, H. N. (2023). plant secondary metabolites on efflux-mediated antibiotic resistant stenotrophomonas maltophilia: Potential of herbal-derived efflux pump inhibitors. Antibiotics, 12(2), 421. https:\/\/doi.org\/10.3390\/antibiotics12020421","journal-title":"Antibiotics"},{"issue":"10","key":"1329_CR22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2478\/s11756-014-0449-6","volume":"69","author":"RS Singh","year":"2014","unstructured":"Singh, R. S., & Thakur, S. (2014). Antimicrobial activity and carbohydrate specificity of new mycelial lectins from Fusarium sp. Biologia, 69(10), 1295\u20131302. https:\/\/doi.org\/10.2478\/s11756-014-0449-6","journal-title":"Biologia"},{"key":"1329_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-03100-8","author":"OM El-Mahdy","year":"2023","unstructured":"El-Mahdy, O. M., Mohamed, H. I., & El-Ansary, A. E. (2023). Optimizations of exopolysaccharide production by Fusarium nygamai strain AJTYC1 and its potential applications as an antioxidant, antimicrobial, anticancer, and emulsifier. BMC Microbiology. https:\/\/doi.org\/10.1186\/s12866-023-03100-8","journal-title":"BMC Microbiology"},{"issue":"45","key":"1329_CR24","doi-asserted-by":"publisher","first-page":"100477","DOI":"10.1007\/s11356-023-29414-8","volume":"30","author":"AE El-Ansary","year":"2023","unstructured":"El-Ansary, A. E., Omran, A. A., Mohamed, H. I., & El-Mahdy, O. M. (2023). Green synthesized silver nanoparticles mediated by Fusarium nygamai isolate AJTYC1: Characterizations, antioxidant, antimicrobial, anticancer, and photocatalytic activities and cytogenetic effects. Environmental Science and Pollution Research, 30(45), 100477\u2013100499. https:\/\/doi.org\/10.1007\/s11356-023-29414-8","journal-title":"Environmental Science and Pollution Research"},{"key":"1329_CR25","doi-asserted-by":"publisher","first-page":"104638","DOI":"10.1016\/j.fitote.2020.104638","volume":"146","author":"J Wei","year":"2020","unstructured":"Wei, J., & Wu, B. (2020). Chemistry and bioactivities of secondary metabolites from the genus Fusarium. Fitoterapia, 146, 104638. https:\/\/doi.org\/10.1016\/j.fitote.2020.104638","journal-title":"Fitoterapia"},{"key":"1329_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00065","author":"WK Mousa","year":"2013","unstructured":"Mousa, W. K., & Raizada, M. N. (2013). The diversity of anti-microbial secondary metabolites produced by fungal endophytes: An interdisciplinary perspective. Frontiers in Microbiology. https:\/\/doi.org\/10.3389\/fmicb.2013.00065","journal-title":"Frontiers in Microbiology"},{"key":"1329_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.fitote.2017.04.007","volume":"119","author":"JO Kyekyeku","year":"2017","unstructured":"Kyekyeku, J. O., Kusari, S., Adosraku, R. K., Bullach, A., Golz, C., Strohmann, C., & Spiteller, M. (2017). Antibacterial secondary metabolites from an endophytic fungus, Fusarium solani JK10. Fitoterapia, 119, 108\u2013114. https:\/\/doi.org\/10.1016\/j.fitote.2017.04.007","journal-title":"Fitoterapia"},{"issue":"5","key":"1329_CR28","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1080\/07391102.2021.2024261","volume":"41","author":"OO Oyedara","year":"2022","unstructured":"Oyedara, O. O., Fadare, O. A., Franco-Fr\u00edas, E., Heredia, N., & Garc\u00eda, S. (2022). Computational assessment of phytochemicals of medicinal plants from Mexico as potential inhibitors of Salmonella enterica efflux pump AcrB protein. Journal of Biomolecular Structure and Dynamics, 41(5), 1776\u20131789. https:\/\/doi.org\/10.1080\/07391102.2021.2024261","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"1329_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2291547","author":"T Phan","year":"2023","unstructured":"Phan, T., Tuong, L., Nguyen, V., Vo, C. T., Tran, T., Le, M., Nguyen, B. G. D., Tran, V., Vu, T., & Thai, K. (2023). Computational assessment and in vitro test of phytochemicals of Usnea aciculifera as potential inhibitors of Escherichia coli efflux pump AcrB. Journal of Biomolecular Structure and Dynamics. https:\/\/doi.org\/10.1080\/07391102.2023.2291547","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"1329_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2246568","author":"S Dey","year":"2023","unstructured":"Dey, S., Rathod, S., Gumphalwad, K., Yadav, N., Choudhari, P., Rajakumara, E., Dhavale, R., & Mahuli, D. (2023). Exploring \u03b1, \u03b2-unsaturated carbonyl compounds against bacterial efflux pumps via computational approach. Journal of Biomolecular Structure and Dynamics. https:\/\/doi.org\/10.1080\/07391102.2023.2246568","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"5","key":"1329_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1389450119666181022153016","volume":"20","author":"S Saikia","year":"2018","unstructured":"Saikia, S., & Bordoloi, M. (2018). Molecular docking: Challenges, advances and its use in drug discovery perspective. Current Drug Targets, 20(5), 501\u2013521. https:\/\/doi.org\/10.2174\/1389450119666181022153016","journal-title":"Current Drug Targets"},{"issue":"28","key":"1329_CR32","doi-asserted-by":"publisher","first-page":"7750","DOI":"10.1021\/acs.jpcb.1c04614","volume":"125","author":"CN Nassab","year":"2021","unstructured":"Nassab, C. N., Arooj, M., Shehadi, I. A., Parambath, J. B. M., Kanan, S. M., & Mohamed, A. A. (2021). Lysozyme and human serum albumin proteins as potential nitric oxide cardiovascular drug carriers: Theoretical and experimental investigation. The Journal of Physical Chemistry B, 125(28), 7750\u20137762. https:\/\/doi.org\/10.1021\/acs.jpcb.1c04614","journal-title":"The Journal of Physical Chemistry B"},{"issue":"3","key":"1329_CR33","doi-asserted-by":"publisher","first-page":"e59278","DOI":"10.1371\/journal.pone.0059278","volume":"8","author":"S Sakkiah","year":"2013","unstructured":"Sakkiah, S., Arooj, M., Cao, G. P., & Lee, K. W. (2013). Insight the C-site pocket conformational changes responsible for Sirtuin 2 activity using molecular dynamics simulations. PLoS ONE, 8(3), e59278. https:\/\/doi.org\/10.1371\/journal.pone.0059278","journal-title":"PLoS ONE"},{"issue":"8","key":"1329_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","volume":"16","author":"A Lagunin","year":"2000","unstructured":"Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000). PASS: Prediction of activity spectra for biologically active substances. Bioinformatics, 16(8), 747\u2013748. https:\/\/doi.org\/10.1093\/bioinformatics\/16.8.747","journal-title":"Bioinformatics"},{"issue":"9","key":"1329_CR35","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1021\/tx200211v","volume":"24","author":"NA Meanwell","year":"2011","unstructured":"Meanwell, N. A. (2011). Improving drug candidates by design: A focus on physicochemical properties as a means of improving compound disposition and safety. Chemical Research in Toxicology, 24(9), 1420\u20131456. https:\/\/doi.org\/10.1021\/tx200211v","journal-title":"Chemical Research in Toxicology"},{"issue":"5","key":"1329_CR36","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1021\/jm050468i","volume":"49","author":"Q Zhang","year":"2006","unstructured":"Zhang, Q., & Muegge, I. (2006). Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: Ranking, voting, and consensus scoring. Journal of Medicinal Chemistry, 49(5), 1536\u20131548. https:\/\/doi.org\/10.1021\/jm050468i","journal-title":"Journal of Medicinal Chemistry"},{"issue":"W1","key":"1329_CR37","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257\u2013W263. https:\/\/doi.org\/10.1093\/nar\/gky318","journal-title":"Nucleic Acids Research"},{"key":"1329_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-6815-2_7","volume-title":"Molecular dynamics simulation of protein and protein-ligand complexes","author":"R Shukla","year":"2020","unstructured":"Shukla, R., & Tripathi, T. (2020). Molecular dynamics simulation of protein and protein-ligand complexes. Springer. https:\/\/doi.org\/10.1007\/978-981-15-6815-2_7"},{"issue":"2","key":"1329_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/ct900549r","volume":"6","author":"P Bjelkmar","year":"2010","unstructured":"Bjelkmar, P., Larsson, P., Cuendet, M. A., Hess, B., & Lindahl, E. (2010). Implementation of the CHARMM force field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models. Journal of Chemical Theory and Computation, 6(2), 459\u2013466. https:\/\/doi.org\/10.1021\/ct900549r","journal-title":"Journal of Chemical Theory and Computation"},{"key":"1329_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-10480-1_6","author":"AM Abdel-Azeem","year":"2019","unstructured":"Abdel-Azeem, A. M., Abdel-Azeem, M. A., Darwish, A. G., Nafady, N. A., & Ibrahim, N. A. (2019). Fusarium: Biodiversity, ecological significances, and industrial applications. Recent Advancement in White Biotechnology Through Fungi. https:\/\/doi.org\/10.1007\/978-3-030-10480-1_6","journal-title":"Recent Advancement in White Biotechnology Through Fungi"},{"key":"1329_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-444-63504-4.00018-9","author":"M Vasundhara","year":"2019","unstructured":"Vasundhara, M., Reddy, M. S., & Kumar, A. (2019). Secondary metabolites from endophytic fungi and their biological activities. New And Future Developments in Microbial Biotechnology and Bioengineering. https:\/\/doi.org\/10.1016\/b978-0-444-63504-4.00018-9","journal-title":"New And Future Developments in Microbial Biotechnology and Bioengineering"},{"key":"1329_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.phytol.2018.11.024","volume":"29","author":"MT Khayat","year":"2019","unstructured":"Khayat, M. T., Ibrahim, S. R., Mohamed, G. A., & Abdallah, H. M. (2019). Anti-inflammatory metabolites from endophytic fungus Fusarium sp. Phytochemistry Letters, 29, 104\u2013109. https:\/\/doi.org\/10.1016\/j.phytol.2018.11.024","journal-title":"Phytochemistry Letters"},{"issue":"23","key":"1329_CR43","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1080\/14786419.2020.1762185","volume":"35","author":"MW Al-Rabia","year":"2020","unstructured":"Al-Rabia, M. W., Mohamed, G. A., Ibrahim, S. R. M., & Asfour, H. Z. (2020). Anti-inflammatory ergosterol derivatives from the endophytic fungus Fusarium chlamydosporum. Natural Product Research, 35(23), 5011\u20135020. https:\/\/doi.org\/10.1080\/14786419.2020.1762185","journal-title":"Natural Product Research"},{"issue":"4","key":"1329_CR44","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1080\/14786419.2020.1855165","volume":"36","author":"GA Mohamed","year":"2020","unstructured":"Mohamed, G. A., Ibrahim, S. R. M., Alhakamy, N. A., & Aljohani, O. S. (2020). Fusaroxazin, a novel cytotoxic and antimicrobial xanthone derivative from Fusarium oxysporum. Natural Product Research, 36(4), 952\u2013960. https:\/\/doi.org\/10.1080\/14786419.2020.1855165","journal-title":"Natural Product Research"},{"issue":"3","key":"1329_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/jof4030077","volume":"4","author":"S Deshmukh","year":"2018","unstructured":"Deshmukh, S., Gupta, M., Prakash, V., & Saxena, S. (2018). Endophytic fungi: A source of potential antifungal compounds. Journal of Fungi, 4(3), 77. https:\/\/doi.org\/10.3390\/jof4030077","journal-title":"Journal of Fungi"},{"key":"1329_CR46","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.bcab.2019.101043","volume":"18","author":"H Farhat","year":"2019","unstructured":"Farhat, H., Urooj, F., Tariq, A., Sultana, V., Ansari, M., Ahmad, V. U., & Ehteshamul-Haque, S. (2019). Evaluation of antimicrobial potential of endophytic fungi associated with healthy plants and characterization of compounds produced by endophytic Cephalosporium and Fusarium solani. Biocatalysis and Agricultural Biotechnology, 18, 101043. https:\/\/doi.org\/10.1016\/j.bcab.2019.101043","journal-title":"Biocatalysis and Agricultural Biotechnology"},{"issue":"12","key":"1329_CR47","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3390\/microorganisms8121934","volume":"8","author":"MC Manganyi","year":"2020","unstructured":"Manganyi, M. C., & Ateba, C. N. (2020). Untapped potentials of endophytic fungi: A review of novel bioactive compounds with biological applications. Microorganisms, 8(12), 1934. https:\/\/doi.org\/10.3390\/microorganisms8121934","journal-title":"Microorganisms"},{"issue":"3","key":"1329_CR48","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jep.2012.01.041","volume":"140","author":"D Barlow","year":"2012","unstructured":"Barlow, D., Buriani, A., Ehrman, T., Bosisio, E., Eberini, I., & Hylands, P. (2012). In-silico studies in Chinese herbal medicines\u2019 research: Evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date. Journal of Ethnopharmacology, 140(3), 526\u2013534. https:\/\/doi.org\/10.1016\/j.jep.2012.01.041","journal-title":"Journal of Ethnopharmacology"},{"key":"1329_CR49","doi-asserted-by":"publisher","first-page":"104851","DOI":"10.1016\/j.compbiomed.2021.104851","volume":"137","author":"B Shaker","year":"2021","unstructured":"Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021). In silico methods and tools for drug discovery. Computers in Biology and Medicine, 137, 104851. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104851","journal-title":"Computers in Biology and Medicine"},{"issue":"5","key":"1329_CR50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2174\/1573399815666190326120006","volume":"15","author":"T Khan","year":"2019","unstructured":"Khan, T., Lawrence, A. J., Azad, I., Raza, S., Joshi, S., & Khan, A. R. (2019). Computational drug designing and prediction of important parameters using in silico methods-a review. Current Computer-Aided Drug Design, 15(5), 384\u2013397. https:\/\/doi.org\/10.2174\/1573399815666190326120006","journal-title":"Current Computer-Aided Drug Design"},{"key":"1329_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100542","author":"SQ Pantale\u00e3o","year":"2021","unstructured":"Pantale\u00e3o, S. Q., Fernandes, P. O., Gon\u00e7alves, J. E., Maltarollo, V. G., & Honorio, K. M. (2021). Recent advances in the prediction of pharmacokinetics properties in drug design studies: A review. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.202100542","journal-title":"ChemMedChem"},{"issue":"10","key":"1329_CR52","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/s0223-5234(99)80031-2","volume":"33","author":"OA Raevsky","year":"1998","unstructured":"Raevsky, O. A., & Schaper, K. J. (1998). Quantitative estimation of hydrogen bond contribution to permeability and absorption processes of some chemicals and drugs. European Journal of Medicinal Chemistry, 33(10), 799\u2013807. https:\/\/doi.org\/10.1016\/s0223-5234(99)80031-2","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"6","key":"1329_CR53","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.copbio.2007.10.005","volume":"18","author":"MQ Zhang","year":"2007","unstructured":"Zhang, M. Q., & Wilkinson, B. (2007). Drug discovery beyond the \u2018rule-of-five.\u2019 Current Opinion in Biotechnology, 18(6), 478\u2013488. https:\/\/doi.org\/10.1016\/j.copbio.2007.10.005","journal-title":"Current Opinion in Biotechnology"},{"issue":"2","key":"1329_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/17460441.2012.648612","volume":"7","author":"WP Walters","year":"2012","unstructured":"Walters, W. P. (2012). Going further than Lipinski\u2019s rule in drug design. Expert Opinion on Drug Discovery, 7(2), 99\u2013107. https:\/\/doi.org\/10.1517\/17460441.2012.648612","journal-title":"Expert Opinion on Drug Discovery"},{"key":"1329_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201800387","author":"AA El-Helby","year":"2019","unstructured":"El-Helby, A. A., Ayyad, R. R. A., Zayed, M. F., Abulkhair, H. S., Elkady, H., & El-Adl, K. (2019). Design, synthesis, in silico ADMET profile and GABA-A docking of novel phthalazines as potent anticonvulsants. Archiv Der Pharmazie. https:\/\/doi.org\/10.1002\/ardp.201800387","journal-title":"Archiv Der Pharmazie"},{"issue":"10","key":"1329_CR56","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/md20100610","volume":"20","author":"TRL Senadheera","year":"2022","unstructured":"Senadheera, T. R. L., Hossain, A., Dave, D., & Shahidi, F. (2022). In silico analysis of bioactive peptides produced from underutilized sea cucumber by-products\u2014A bioinformatics approach. Marine Drugs, 20(10), 610. https:\/\/doi.org\/10.3390\/md20100610","journal-title":"Marine Drugs"},{"issue":"42","key":"1329_CR57","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1021\/acs.biochem.7b00747","volume":"56","author":"A Manglik","year":"2017","unstructured":"Manglik, A., & Kruse, A. C. (2017). Structural basis for G protein-coupled receptor activation. Biochemistry, 56(42), 5628\u20135634. https:\/\/doi.org\/10.1021\/acs.biochem.7b00747","journal-title":"Biochemistry"},{"issue":"12","key":"1329_CR58","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/cbic.201100236","volume":"12","author":"S Dilly","year":"2011","unstructured":"Dilly, S., Lamy, C., Marrion, N. V., Li\u00e9geois, J., & Seutin, V. (2011). Ion-channel modulators: More diversity than previously thought. ChemBioChem, 12(12), 1808\u20131812. https:\/\/doi.org\/10.1002\/cbic.201100236","journal-title":"ChemBioChem"},{"key":"1329_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-802381-5.00002-6","author":"B Barker","year":"2017","unstructured":"Barker, B., Young, G., Soubrane, C., Stephens, G., Stevens, E., & Patel, M. (2017). Ion channels. Conn\u2019s Translational Neuroscience. https:\/\/doi.org\/10.1016\/b978-0-12-802381-5.00002-6","journal-title":"Conn\u2019s Translational Neuroscience"},{"issue":"3","key":"1329_CR60","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nbt1068","volume":"23","author":"MA Fabian","year":"2005","unstructured":"Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., Ford, J. M., Galvin, M., Gerlach, J. L., Grotzfeld, R. M., Herrgard, S., Insko, D. E., Insko, M. A., Lai, A. G., L\u00e9lias, J. M., & Lockhart, D. J. (2005). A small molecule\u2013kinase interaction map for clinical kinase inhibitors. Nature Biotechnology, 23(3), 329\u2013336. https:\/\/doi.org\/10.1038\/nbt1068","journal-title":"Nature Biotechnology"},{"issue":"1\u20132","key":"1329_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mce.2010.06.018","volume":"334","author":"FM Sladek","year":"2011","unstructured":"Sladek, F. M. (2011). What are nuclear receptor ligands? Molecular and Cellular Endocrinology, 334(1\u20132), 3\u201313. https:\/\/doi.org\/10.1016\/j.mce.2010.06.018","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"1329_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/09723757.2007.11885986","volume":"7","author":"R Pandey","year":"2007","unstructured":"Pandey, R., Patil, N., & Rao, M. (2007). Proteases and protease inhibitors: Implications in antitumorigenesis and drug development. International Journal of Human Genetics, 7(1), 67\u201382. https:\/\/doi.org\/10.1080\/09723757.2007.11885986","journal-title":"International Journal of Human Genetics"},{"issue":"1","key":"1329_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1472-8206.2007.00548.x","volume":"22","author":"Y Landry","year":"2008","unstructured":"Landry, Y., & Gies, J. (2008). Drugs and their molecular targets: An updated overview. Fundamental & Clinical Pharmacology, 22(1), 1\u201318. https:\/\/doi.org\/10.1111\/j.1472-8206.2007.00548.x","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"4","key":"1329_CR64","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ejps.2013.05.019","volume":"49","author":"E Sj\u00f6gren","year":"2013","unstructured":"Sj\u00f6gren, E., Westergren, J., Grant, I., Hanisch, G., Lindfors, L., Lennern\u00e4s, H., Abrahamsson, B., & Tannergren, C. (2013). In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim. European Journal of Pharmaceutical Sciences, 49(4), 679\u2013698. https:\/\/doi.org\/10.1016\/j.ejps.2013.05.019","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"31","key":"1329_CR65","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.2174\/092986709789378198","volume":"16","author":"B Wang","year":"2009","unstructured":"Wang, B., & Zhou, S. F. (2009). Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Current Medicinal Chemistry, 16(31), 4066\u20134218. https:\/\/doi.org\/10.2174\/092986709789378198","journal-title":"Current Medicinal Chemistry"},{"issue":"23","key":"1329_CR66","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","volume":"22","author":"M Zhao","year":"2021","unstructured":"Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., He, L., & Qin, S. (2021). Cytochrome P450 enzymes and drug metabolism in humans. International Journal of Molecular Sciences, 22(23), 12808. https:\/\/doi.org\/10.3390\/ijms222312808","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"1329_CR67","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/03602530903286476","volume":"42","author":"SF Zhou","year":"2009","unstructured":"Zhou, S. F., Wang, B., Yang, L. P., & Liu, J. P. (2009). Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metabolism Reviews, 42(2), 268\u2013354. https:\/\/doi.org\/10.3109\/03602530903286476","journal-title":"Drug Metabolism Reviews"},{"issue":"1","key":"1329_CR68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1389200221999210101233135","volume":"22","author":"J Guo","year":"2021","unstructured":"Guo, J., Zhu, X., Badawy, S., Ihsan, A., Liu, Z., Xie, C., & Wang, X. (2021). Metabolism and mechanism of human cytochrome P450 enzyme 1A2. Current Drug Metabolism, 22(1), 40\u201349. https:\/\/doi.org\/10.2174\/1389200221999210101233135","journal-title":"Current Drug Metabolism"},{"issue":"5","key":"1329_CR69","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40262-021-01001-5","volume":"60","author":"Y Song","year":"2021","unstructured":"Song, Y., Li, C., Liu, G., Liu, R., Chen, Y., Li, W., Cao, Z., Zhao, B., Lu, C., & Liu, Y. (2021). Drug-metabolizing cytochrome P450 enzymes have multifarious influences on treatment outcomes. Clinical Pharmacokinetics, 60(5), 585\u2013601. https:\/\/doi.org\/10.1007\/s40262-021-01001-5","journal-title":"Clinical Pharmacokinetics"},{"issue":"5","key":"1329_CR70","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.coph.2013.06.001","volume":"13","author":"A Roncaglioni","year":"2013","unstructured":"Roncaglioni, A., Toropov, A. A., Toropova, A. P., & Benfenati, E. (2013). In silico methods to predict drug toxicity. Current Opinion in Pharmacology, 13(5), 802\u2013806. https:\/\/doi.org\/10.1016\/j.coph.2013.06.001","journal-title":"Current Opinion in Pharmacology"},{"issue":"3","key":"1329_CR71","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1021\/acs.jcim.9b01062","volume":"60","author":"M Majewski","year":"2020","unstructured":"Majewski, M., & Barril, X. (2020). Structural stability predicts the binding mode of protein-ligand complexes. Journal of Chemical Information and Modeling, 60(3), 1644\u20131651. https:\/\/doi.org\/10.1021\/acs.jcim.9b01062","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"2","key":"1329_CR72","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0022-2836(02)00777-5","volume":"322","author":"BQ Wei","year":"2002","unstructured":"Wei, B. Q., Baase, W. A., Weaver, L. H., Matthews, B. W., & Shoichet, B. K. (2002). A model binding site for testing scoring functions in molecular docking. Journal of Molecular Biology, 322(2), 339\u2013355. https:\/\/doi.org\/10.1016\/s0022-2836(02)00777-5","journal-title":"Journal of Molecular Biology"},{"key":"1329_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-38827-4_6","author":"E L\u00f3pez-Camacho","year":"2016","unstructured":"L\u00f3pez-Camacho, E., Garc\u00eda-Godoy, M. J., Garc\u00eda-Nieto, J., Nebro, A. J., & Aldana-Montes, J. F. (2016). A new multi-objective approach for molecular docking based on RMSD and binding energy. Algorithms for Computational Biology. https:\/\/doi.org\/10.1007\/978-3-319-38827-4_6","journal-title":"Algorithms for Computational Biology"},{"key":"1329_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9752-7_7","author":"G Bitencourt-Ferreira","year":"2019","unstructured":"Bitencourt-Ferreira, G., Veit-Acosta, M., & De Azevedo, W. F. (2019). Hydrogen bonds in protein-ligand complexes. Methods in Molecular Biology. https:\/\/doi.org\/10.1007\/978-1-4939-9752-7_7","journal-title":"Methods in Molecular Biology"},{"issue":"1","key":"1329_CR75","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/prot.21253","volume":"67","author":"SK Panigrahi","year":"2007","unstructured":"Panigrahi, S. K., & Desiraju, G. R. (2007). Strong and weak hydrogen bonds in the protein\u2013ligand interface. Proteins Structure Function and Bioinformatics, 67(1), 128\u2013141. https:\/\/doi.org\/10.1002\/prot.21253","journal-title":"Proteins Structure Function and Bioinformatics"},{"issue":"8","key":"1329_CR76","doi-asserted-by":"publisher","first-page":"e12029","DOI":"10.1371\/journal.pone.0012029","volume":"5","author":"R Patil","year":"2010","unstructured":"Patil, R., Das, S., Stanley, A., Yadav, L., Sudhakar, A., & Varma, A. K. (2010). Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS ONE, 5(8), e12029. https:\/\/doi.org\/10.1371\/journal.pone.0012029","journal-title":"PLoS ONE"},{"issue":"11","key":"1329_CR77","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1021\/ml400211q","volume":"4","author":"JM Myslinski","year":"2013","unstructured":"Myslinski, J. M., Clements, J. H., DeLorbe, J. E., & Martin, S. F. (2013). Protein-ligand interactions: Thermodynamic effects associated with increasing the length of an alkyl chain. ACS Medicinal Chemistry Letters, 4(11), 1048\u20131053. https:\/\/doi.org\/10.1021\/ml400211q","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"4","key":"1329_CR78","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/prot.21396","volume":"68","author":"IS Moreira","year":"2007","unstructured":"Moreira, I. S., Fernandes, P. A., & Ramos, M. J. (2007). Hot spots: A review of the protein\u2013protein interface determinant amino-acid residues. Proteins: Structure, Function, and Bioinformatics, 68(4), 803\u2013812. https:\/\/doi.org\/10.1002\/prot.21396","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"issue":"8","key":"1329_CR79","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd.2016.29","volume":"15","author":"DE Scott","year":"2016","unstructured":"Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016). Small molecules, big targets: Drug discovery faces the protein\u2013protein interaction challenge. Nature Reviews Drug Discovery, 15(8), 533\u2013550. https:\/\/doi.org\/10.1038\/nrd.2016.29","journal-title":"Nature Reviews Drug Discovery"},{"issue":"2","key":"1329_CR80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijmr.ijmr_2079_17","volume":"149","author":"A Sharma","year":"2019","unstructured":"Sharma, A., Gupta, V. K., & Pathania, R. (2019). Efflux pump inhibitors for bacterial pathogens: From bench to bedside. The Indian Journal of Medical Research, 149(2), 129. https:\/\/doi.org\/10.4103\/ijmr.ijmr_2079_17","journal-title":"The Indian Journal of Medical Research"},{"issue":"10","key":"1329_CR81","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.drudis.2020.07.011","volume":"25","author":"E Rathi","year":"2020","unstructured":"Rathi, E., Kumar, A., & Kini, S. G. (2020). Computational approaches in efflux pump inhibitors: Current status and prospects. Drug Discovery Today, 25(10), 1883\u20131890. https:\/\/doi.org\/10.1016\/j.drudis.2020.07.011","journal-title":"Drug Discovery Today"},{"issue":"2","key":"1329_CR82","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/157489106777452692","volume":"1","author":"F Bambeke","year":"2006","unstructured":"Bambeke, F., Pages, J., & Lee, V. (2006). Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Patents on Anti-Infective Drug Discovery, 1(2), 157\u2013175. https:\/\/doi.org\/10.2174\/157489106777452692","journal-title":"Recent Patents on Anti-Infective Drug Discovery"},{"issue":"22","key":"1329_CR83","doi-asserted-by":"publisher","first-page":"12503","DOI":"10.1080\/07391102.2023.2175381","volume":"41","author":"T Phan","year":"2023","unstructured":"Phan, T., Nguyen, V., Nguyen, C., Vu, T., Tran, T., Le, M., Trinh, D. T., Tran, V., & Thai, K. (2023). Discovery of AcrAB-TolC pump inhibitors: Virtual screening and molecular dynamics simulation approach. Journal of Biomolecular Structure and Dynamics, 41(22), 12503\u201312520. https:\/\/doi.org\/10.1080\/07391102.2023.2175381","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"1","key":"1329_CR84","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/nyas.14239","volume":"1459","author":"J Kobylka","year":"2019","unstructured":"Kobylka, J., Kuth, M. S., M\u00fcller, R. T., Geertsma, E. R., & Pos, K. M. (2019). AcrB: A mean, keen, drug efflux machine. Annals of the New York Academy of Sciences, 1459(1), 38\u201368. https:\/\/doi.org\/10.1111\/nyas.14239","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"9","key":"1329_CR85","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1021\/acs.chemrev.0c01226","volume":"121","author":"PJF Henderson","year":"2021","unstructured":"Henderson, P. J. F., Maher, C., Elbourne, L. D. H., Eijkelkamp, B. A., Paulsen, I. T., & Hassan, K. A. (2021). Physiological functions of bacterial \u201cmultidrug\u201d efflux pumps. Chemical Reviews, 121(9), 5417\u20135478. https:\/\/doi.org\/10.1021\/acs.chemrev.0c01226","journal-title":"Chemical Reviews"},{"issue":"11","key":"1329_CR86","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1002\/jcb.26064","volume":"118","author":"DT Kumar","year":"2017","unstructured":"Kumar, D. T., Lavanya, P., Doss, C. G. P., Tayubi, I. A., Kumar, D. R. N., Yesurajan, I. F., Siva, R., & Balaji, V. (2017). A molecular docking and dynamics approach to screen potent inhibitors against Fosfomycin resistant enzyme in clinical Klebsiella pneumoniae. Journal of Cellular Biochemistry, 118(11), 4088\u20134094. https:\/\/doi.org\/10.1002\/jcb.26064","journal-title":"Journal of Cellular Biochemistry"},{"issue":"2","key":"1329_CR87","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.arabjc.2015.07.010","volume":"12","author":"US Tambunan","year":"2019","unstructured":"Tambunan, U. S., Parikesit, A. A., Ghifari, A. S., & Satriyanto, C. P. (2019). In silico identification of 2-oxo-1,3-thiazolidine derivatives as novel inhibitor candidate of class II histone deacetylase (HDAC) in cervical cancer treatment. Arabian Journal of Chemistry, 12(2), 272\u2013288. https:\/\/doi.org\/10.1016\/j.arabjc.2015.07.010","journal-title":"Arabian Journal of Chemistry"},{"key":"1329_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57124-9","author":"K Nyambo","year":"2024","unstructured":"Nyambo, K., Tapfuma, K. I., Adu-Amankwaah, F., Julius, L., Baatjies, L., Niang, I. S., Smith, L., Govender, K. K., Ngxande, M., Watson, D. J., Wiesner, L., & Mavumengwana, V. (2024). Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-024-57124-9","journal-title":"Scientific Reports"},{"issue":"6","key":"1329_CR89","doi-asserted-by":"publisher","first-page":"e0303285","DOI":"10.1371\/journal.pone.0303285","volume":"19","author":"I Shafique","year":"2024","unstructured":"Shafique, I., Rafiq, M., Rana, N. F., Menaa, F., Almalki, F., Aljuaid, A., Alnasser, S. M., Alotaibi, A. S., Masood, M. B. E., & Tanweer, T. (2024). Computational evaluation of efflux pump homologues and lignans as potent inhibitors against multidrug-resistant Salmonella typhi. PLoS ONE, 19(6), e0303285. https:\/\/doi.org\/10.1371\/journal.pone.0303285","journal-title":"PLoS ONE"},{"issue":"1","key":"1329_CR90","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/molecules28010219","volume":"28","author":"F Ahmmed","year":"2022","unstructured":"Ahmmed, F., Islam, A. U., Mukhrish, Y. E., Bakri, Y. E., Ahmad, S., Ozeki, Y., & Kawsar, S. M. A. (2022). Efficient antibacterial\/antifungal activities: Synthesis, molecular docking, molecular dynamics, pharmacokinetic, and binding free energy of galactopyranoside derivatives. Molecules\/Molecules Online\/Molecules Annual, 28(1), 219. https:\/\/doi.org\/10.3390\/molecules28010219","journal-title":"Molecules\/Molecules Online\/Molecules Annual"},{"issue":"4","key":"1329_CR91","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","volume":"13","author":"K Sargsyan","year":"2017","unstructured":"Sargsyan, K., Grauffel, C., & Lim, C. (2017). How molecular size impacts RMSD applications in molecular dynamics simulations. Journal of Chemical Theory and Computation, 13(4), 1518\u20131524. https:\/\/doi.org\/10.1021\/acs.jctc.7b00028","journal-title":"Journal of Chemical Theory and Computation"},{"key":"1329_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-023-00831-x","author":"AM Da Fonseca","year":"2023","unstructured":"Da Fonseca, A. M., Caluaco, B. J., Madureira, J. M. C., Cabongo, S. Q., Gaieta, E. M., Djata, F., Colares, R. P., Neto, M. M., Fernandes, C. F. C., Marinho, G. S., Santos, H. S. D., & Marinho, E. S. (2023). Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking, and approach with molecular dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA. Molecular Biotechnology. https:\/\/doi.org\/10.1007\/s12033-023-00831-x","journal-title":"Molecular Biotechnology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01329-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01329-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01329-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:12:51Z","timestamp":1763615571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01329-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01329-w","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}